Our results suggest the hypothesis that other cell types may be responsible for this increase in ALDH1A2 expression, as cells which co-stain for GFAP, a tumor cell, and reactive astrocyte markers were found in GBM tumors (data not shown). The gene discussed is ALDH1A2; the disease is neoplasm.